BRPI0413332A - dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos - Google Patents
dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicosInfo
- Publication number
- BRPI0413332A BRPI0413332A BRPI0413332-3A BRPI0413332A BRPI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A
- Authority
- BR
- Brazil
- Prior art keywords
- markers
- well
- body fluid
- fluid sample
- disease states
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 210000001124 body fluid Anatomy 0.000 title abstract 3
- 239000010839 body fluid Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000001575 pathological effect Effects 0.000 abstract 2
- 238000011158 quantitative evaluation Methods 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
"DISPOSITIVO E PROCESSO PARA AVALIAçãO QUANTITATIVA DOS POLIPETìDEOS CONTIDOS EM UMA AMOSTRA DE FLUIDO CORPORAL BEM COMO MARCADORES PARA IDENTIFICAçãO DE ESTADOS PATOLóGICOS". A presente invenção refere-se a dispositivos e processos para a avaliação quantitativa dos polipeptídeos contidos em uma amostra de fluido corporal e comparação com valores de referência armazenados em um banco de dados bem como marcadores para identificação de estados patológicos que são descritos. Os polipeptídeos são comparados com valores de referência armazenados em um banco de dados. Esses valores de referência são armazenados como conjuntos de dados de polipeptídeos relevantes ao estado, que abrangem respectivamente ao menos uma indicação sobre a probabilidade para a ocorrência ou a concentração dos polipeptídeos para um estado patológico em amostras de indivíduos testados saudáveis e doentes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10341193A DE10341193A1 (de) | 2003-09-06 | 2003-09-06 | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen |
| PCT/EP2004/009833 WO2005024409A1 (de) | 2003-09-06 | 2004-09-03 | Vorrichtung und verfahren zur quantitativen auswertung der in einer körperflüssigkeitsprobe enthaltenen polypeptide sowie marker zur erkennung von pathologischen zuständen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0413332A true BRPI0413332A (pt) | 2006-10-10 |
Family
ID=34223428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0413332-3A BRPI0413332A (pt) | 2003-09-06 | 2004-09-03 | dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070082402A1 (pt) |
| EP (1) | EP1660880A1 (pt) |
| JP (1) | JP4765078B2 (pt) |
| KR (1) | KR20060132558A (pt) |
| CN (1) | CN1846133A (pt) |
| AU (1) | AU2004270861B9 (pt) |
| BR (1) | BRPI0413332A (pt) |
| CA (1) | CA2537588A1 (pt) |
| DE (1) | DE10341193A1 (pt) |
| RU (1) | RU2425374C2 (pt) |
| WO (1) | WO2005024409A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
| EP1869473A2 (de) * | 2005-04-06 | 2007-12-26 | mosaiques diagnostics and therapeutics AG | Polypeptidmarker zur diagnose von alzheimer |
| BRPI0607016A2 (pt) * | 2005-04-07 | 2009-08-04 | Mosaiques Diagnostics & Therap | marcadores polipeptìdicos para o diagnóstico de cáncer de próstata |
| JP5155857B2 (ja) * | 2005-06-29 | 2013-03-06 | モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト | 移植腎の拒絶の早期認識のためのポリペプチドマーカー |
| EP2118666B1 (de) * | 2007-03-07 | 2011-08-03 | Mosaiques Diagnostics And Therapeutics AG | Verfahren zur normierung der konzentration von analyten in einer urinprobe |
| EP1972940A1 (de) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Nierenerkrankungen |
| WO2009047280A2 (de) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnose von prostatakrebs |
| EP2051078A1 (de) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Diabetes Mellitus |
| WO2009115570A2 (de) * | 2008-03-19 | 2009-09-24 | Mosaiques Diagnostics And Therapeutics Ag | Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen |
| WO2010031822A1 (de) * | 2008-09-17 | 2010-03-25 | Mosaiques Diagnostics And Therapeutics Ag | Nierenzellkarzinom |
| CA3146525A1 (en) | 2019-08-05 | 2021-02-11 | William Manning | Systems and methods for sample preparation, data generation, and protein corona analysis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875616B1 (en) * | 1996-08-13 | 2005-04-05 | Biovision Ag | Process for determining the status of an organism by peptide measurement |
| DE19702774C2 (de) * | 1997-01-27 | 2002-04-18 | Pe Diagnostik Gmbh | Verfahren zur Ermittlung von Daten für eine Wissensbank und ihre Verwendung bei der Analyse von Gleichgewichtssituationen der in Wechselwirkung befindlichen Mineralien und Spurenelemente in Körperflüssigkeiten |
| DE19919982C2 (de) * | 1999-04-30 | 2001-06-28 | Pe Diagnostik Gmbh | Verfahren zur Ermittlung osteoporotischer Prozesse |
| DE10021737C2 (de) * | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
| DE10021597A1 (de) * | 2000-05-04 | 2001-11-15 | Forschungszentrum Juelich Gmbh | Verfahren zur Optimierung der Parameter eines Trennungsverfahrens für Stoffgemische |
| US20020087273A1 (en) * | 2001-01-04 | 2002-07-04 | Anderson Norman G. | Reference database |
| WO2003019193A1 (en) * | 2001-08-30 | 2003-03-06 | Ciphergen Biosystems, Inc. | Method of diagnosing nephrotic syndrome |
| CN1659431A (zh) * | 2002-02-19 | 2005-08-24 | 新加坡基因组研究院 | 用于等电聚焦的设备 |
-
2003
- 2003-09-06 DE DE10341193A patent/DE10341193A1/de not_active Ceased
-
2004
- 2004-09-03 JP JP2006525719A patent/JP4765078B2/ja not_active Expired - Fee Related
- 2004-09-03 CA CA002537588A patent/CA2537588A1/en not_active Abandoned
- 2004-09-03 US US10/570,708 patent/US20070082402A1/en not_active Abandoned
- 2004-09-03 RU RU2006111095/15A patent/RU2425374C2/ru not_active IP Right Cessation
- 2004-09-03 BR BRPI0413332-3A patent/BRPI0413332A/pt not_active IP Right Cessation
- 2004-09-03 CN CN200480025529.3A patent/CN1846133A/zh active Pending
- 2004-09-03 WO PCT/EP2004/009833 patent/WO2005024409A1/de active Application Filing
- 2004-09-03 KR KR1020067004500A patent/KR20060132558A/ko not_active Application Discontinuation
- 2004-09-03 EP EP04764788A patent/EP1660880A1/de not_active Withdrawn
- 2004-09-03 AU AU2004270861A patent/AU2004270861B9/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004270861B2 (en) | 2010-11-18 |
| EP1660880A1 (de) | 2006-05-31 |
| AU2004270861B9 (en) | 2011-01-27 |
| WO2005024409A1 (de) | 2005-03-17 |
| KR20060132558A (ko) | 2006-12-21 |
| CN1846133A (zh) | 2006-10-11 |
| CA2537588A1 (en) | 2005-03-17 |
| DE10341193A1 (de) | 2005-03-31 |
| AU2004270861A1 (en) | 2005-03-17 |
| JP2007504466A (ja) | 2007-03-01 |
| JP4765078B2 (ja) | 2011-09-07 |
| RU2006111095A (ru) | 2006-08-10 |
| US20070082402A1 (en) | 2007-04-12 |
| RU2425374C2 (ru) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0413332A (pt) | dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos | |
| ATE411525T1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
| CA2684144C (en) | Measurement and uses of oxidative status | |
| BRPI0509978A (pt) | uso de padrão proteÈmico de plasma para diagnóstico, classificação, previsão de resposta à terapia e comportamento clìnico, estratificação de terapia, e monitoramento de doença em malignidades hematológicas | |
| ATE445160T1 (de) | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon | |
| CY1116147T1 (el) | Μεθοδος για την ταυτοποιηση ενος υποκειμενου που κινδυνευει να παρουσιασει καρδιακη ανεπαρκεια, μεσω του προσδιορισμου του επιπεδου γαλεκτινης-3 ή θρομβοσπονδινης-2 | |
| BRPI0411695A (pt) | dispositivos e métodos relacionados a biossensores eletroquìmicos | |
| JP2007523324A5 (pt) | ||
| ATE536553T1 (de) | Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse | |
| DE60228684D1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| BRPI0516674A (pt) | método de análise de mal de alzheimer e reagente de diagnóstico | |
| NO20050186D0 (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| BR0115715A (pt) | Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata | |
| CY1108182T1 (el) | Μεσα εντοπισμου του παθολογικου μετασχηματισμου της πρωτεϊνης app και εφαρμογες τους | |
| ATE475098T1 (de) | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 | |
| CY1112423T1 (el) | Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης | |
| BRPI0512948A (pt) | biomarcadores de mal de alzheimer | |
| Seidensticker et al. | Sexing young snowy owls | |
| BR0108659A (pt) | Métodos para tratamento ou prevenção ou profilaxia de câncer de mama, para detecção, diagnóstico e/ou avaliação ou prognóstico quanto ao câncer de mama, para monitoração e/ou estimativa de tratamento do câncer de mama, para identificação da presença ou ausência de células de câncer de mama metastáticas em um amostra biológica e para avaliação ou identificação de compostos, usos de uma ou mais bcmps, de uma composição, de um anticorpo, de ácido nucleico e de um agente que interaja com ou module a atividade de uma ou mais bcmps, vacina, composição, kit e anticorpo | |
| BR112022000322A2 (pt) | Um biomarcador para doença de alzheimer com o uso de amostras de sangue de indivíduos clinicamente diagnosticados com doença de alzheimer | |
| BR0102781A (pt) | Processos para identificação de combinações de entidades como terapêuticos | |
| ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
| DE60140346D1 (de) | System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices | |
| Otero et al. | Erythrocyte nuclear size as a better diagnostic character than cell size in the identification of live cryptic polyploid species | |
| Ledogar et al. | Can metric data be an effective tool for galliform skull identification in archaeological contexts? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |